BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7096564)

  • 21. Mapping of a cholinergic binding site by means of synthetic peptides, monoclonal antibodies, and alpha-bungarotoxin.
    Conti-Tronconi BM; Tang F; Diethelm BM; Spencer SR; Reinhardt-Maelicke S; Maelicke A
    Biochemistry; 1990 Jul; 29(26):6221-30. PubMed ID: 2207067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of cross-reactivity of a monoclonal antibody against the neurotransmitter site of Torpedo nicotinic acetylcholine receptor with muscle receptors from several sources.
    James RW; Alliod C; Fulpius BW
    Mol Immunol; 1983 Dec; 20(12):1363-8. PubMed ID: 6140627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subunit structure of alpha-bungarotoxin binding component in mouse brain.
    Seto A; Arimatsu Y; Amano T
    J Neurochem; 1981 Jul; 37(1):210-6. PubMed ID: 7252506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site.
    Mochly-Rosen D; Fuchs S
    Biochemistry; 1981 Sep; 20(20):5920-4. PubMed ID: 7295707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional acetylcholine receptor in PC12 cells reacts with a monoclonal antibody to brain nicotinic receptors.
    Whiting PJ; Schoepfer R; Swanson LW; Simmons DM; Lindstrom JM
    Nature; 1987 Jun 11-17; 327(6122):515-8. PubMed ID: 2438558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of alpha-conotoxin ImII and its analogs with nicotinic receptors and acetylcholine-binding proteins: additional binding sites on Torpedo receptor.
    Kasheverov IE; Zhmak MN; Fish A; Rucktooa P; Khruschov AY; Osipov AV; Ziganshin RH; D'hoedt D; Bertrand D; Sixma TK; Smit AB; Tsetlin VI
    J Neurochem; 2009 Nov; 111(4):934-44. PubMed ID: 19712060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-bungarotoxin binding in house fly heads and Torpedo electroplax.
    Jones SW; Sudershan P; O'Brien RD
    J Neurochem; 1981 Feb; 36(2):447-53. PubMed ID: 7463071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of anti-nicotinic acetylcholine receptor antibodies at alpha-bungarotoxin binding sites across species and tissues.
    Lukas RJ
    Brain Res; 1986 Nov; 387(2):119-25. PubMed ID: 3791005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-bungarotoxin binding to acetylcholine receptor membranes studied by low angle X-ray diffraction.
    Young HS; Herbette LG; Skita V
    Biophys J; 2003 Aug; 85(2):943-53. PubMed ID: 12885641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characterization of alpha-bungarotoxin-binding proteins from Aplysia californica.
    McLaughlin JT; Hawrot E
    Mol Pharmacol; 1989 May; 35(5):593-8. PubMed ID: 2542757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The alpha-bungarotoxin receptor purified from a human neuroblastoma cell line: biochemical and immunological characterization.
    Gotti C; Ogando AE; Clementi F
    Neuroscience; 1989; 32(3):759-67. PubMed ID: 2601844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A functional alpha-bungarotoxin receptor is present in chick cerebellum: purification and characterization.
    Gotti C; Hanke W; Schlue WR; Briscini L; Moretti M; Clementi F
    Neuroscience; 1992 Sep; 50(1):117-27. PubMed ID: 1357590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphological changes observed in rats immunized with the Torpedo acetylcholine receptor alpha-chain.
    Elfman L; Thornell LE; Heilbronn E
    J Neurol Sci; 1983 Apr; 59(1):111-21. PubMed ID: 6602208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of receptor-ligand interactions using nitrocellulose gel transfer: application to Torpedo acetylcholine receptor and alpha-bungarotoxin.
    Oblas B; Boyd ND; Singer RH
    Anal Biochem; 1983 Apr; 130(1):1-8. PubMed ID: 6869791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
    Weiland GA; Durkin JA; Henley JM; Simasko SM
    Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of monoclonal antibodies to nicotinic acetylcholine receptor from chick muscle.
    Mehraban F; Kemshead JT; Dolly JO
    Eur J Biochem; 1984 Jan; 138(1):53-61. PubMed ID: 6692825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. alpha-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain.
    Wonnacott S
    J Neurochem; 1986 Dec; 47(6):1706-12. PubMed ID: 3772372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope mapping employing antibodies raised against short synthetic peptides: a study of the nicotinic acetylcholine receptor.
    Maelicke A; Plümer-Wilk R; Fels G; Spencer SR; Engelhard M; Veltel D; Conti-Tronconi BM
    Biochemistry; 1989 Feb; 28(3):1396-405. PubMed ID: 2469469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymopoietin, a polypeptide ligand for the alpha-bungarotoxin binding site in brain: an autoradiographic study.
    Afar R; Clarke PB; Goldstein G; Quik M
    Neuroscience; 1992; 48(3):641-53. PubMed ID: 1603334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.